Aplodan
CAS No. 6903-79-3
Aplodan( Creatinolfosfate | Nergize | Creatinolfosfate, Creatinol Phosphate | creatinol-O-phosphate )
Catalog No. M27339 CAS No. 6903-79-3
Aplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 38 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 83 | In Stock |
|
| 200MG | 123 | In Stock |
|
| 500MG | 214 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAplodan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane.
-
DescriptionAplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane. Aplodan can be used in research on the ischemic heart or ischemic heart disease with persistent ventricular premature beats.
-
In Vitro——
-
In Vivo——
-
SynonymsCreatinolfosfate | Nergize | Creatinolfosfate, Creatinol Phosphate | creatinol-O-phosphate
-
PathwayOthers
-
TargetOther Targets
-
RecptorD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6903-79-3
-
Formula Weight197.131
-
Molecular FormulaC4H12N3O4P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 62.5 mg/mL (317.05 mM)
-
SMILESCN(CCOP(O)(O)=O)C(N)=N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haase AF, et al. Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):588-94.
molnova catalog
related products
-
N-Acetyl-β-Asp-Glu
Spaglumic acid is the β-aspartyl isoform of N-Acetyl-l-aspartylglutamate (isospaglumic Acid is N-(N-Acetyl-l-α-aspartyl)-l-glutamic acid).
-
Alpidem
Alpidem is an anxiolytic drug from the imidazopyridine family. Alpidem does not produce sedative effects at normal doses, and is instead used specifically for the treatment of anxiety. Alpidem has nanomolar binding affinity for both the central benzodiaze
-
Decuroside I
Decuroside I shows weak inhibiting activity against the primary and secondary wave aggregation of human platelet.
Cart
sales@molnova.com